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while another study reported that the post-piezo-ICSI survival rate is lower with low oolemma stretchability than with high oolemma stretchability. 6 Regarding embryonic development, there was a study that reported no association between the degree of oolemma fragility and embryonic development or pregnancy rates. 8 Conversely, one study did find that the implantation rate following transfer was lower for a low stretchability oocyte-derived blastocyst than for a high stretchability oocyte-derived blastocyst. 6 The authors' previous study demonstrated that the oolemma of human metaphase II (MII) oocytes from individual follicles with a low follicular fluid (FF) volume following the gonadotrophin-releasing hormone (GnRH) antagonist protocol were more likely to have a low stretchability during ICSI, suggesting a potential association between the FF volume with oolemma stretchability. 9 However, the relationship between MII oolemma stretchability following the GnRH agonist protocol and the FF volume remains unclear.
The GnRH agonists and antagonists have different effects on the intraovarian autocrine and paracrine systems, as well as on the pituitary gland, to prevent a premature surge of luteinizing hormone during controlled ovarian stimulation (COS). 10, 11 Thus, the GnRH agonist suppresses gonadotrophin secretion through both pituitary desensitization and GnRH receptor downregulation. 12 Conversely, a
GnRH antagonist will rapidly inhibit gonadotrophin secretion by a competitive blockade of GnRH receptors. 13 Accordingly, the potentially different effects of COS on ovarian folliculogenesis could lead to different responses and endocrine environments for maturing oocytes. 14 Several studies have reported a relationship between the type of COS protocol and oocyte quality. Cytoplasmic viscosity 5 and the morphology 15 of the oocytes are not related to the COS protocol, whereas the quality of the zona pellucida is dependent on the COS protocol. 16 Therefore, elucidating the impact of a COS protocol on oolemma stretchability during ICSI is crucial.
The aim of this study was to investigate the relationship between the FF volume that was aspirated from individual follicles and oocyte retrieval, oocyte maturity, the cumulus-oocyte complex (COC) grade, oolemma stretchability, fertilization, and embryonic development following the administration of a short GnRH agonist protocol, according to the outcome measures in the authors' previous GnRH antagonist study. 9 
| MATERIAL S AND ME THODS

| Patients
Data from 74 ICSI cycles that had been performed between April, 2016
and May, 2017 were reviewed retrospectively. The mean (±standard deviation) age of the women was 37.6 ± 4.0 (range: 28-44) years.
| Controlled ovarian stimulation and oocyte retrieval
The COS was performed, as described previously. 17 The patients
were treated with the GnRH analog, acetate (Fuji Pharma Company, Ltd., Tokyo, Japan), and human menopausal gonadotropin (ASKA Pharmaceutical Company, Ltd., Tokyo, Japan) in accordance with the short GnRH agonist protocol. When at least two follicles had reached 18-20 mm in diameter (as determined by transvaginal ultrasonography), 5000 IU of human chorionic gonadotropin (hCG; Fuji Pharma Company) were administered. Oocyte retrieval was performed 36 hours after the hCG injection.
Individual follicles were aspirated, as described previously. 9 In brief, after measuring the diameter, each follicle was individually aspirated and collected. The volume of FF that initially was aspirated from each follicle was measured by using a 10 mL syringe (Terumo Corporation, Tokyo, Japan) that was connected to an ovum pick-up needle (Kitazato OPU Needle; Kitazato Corporation, Shizuoka, Japan), then was decanted into a 60 mm dish (Corning, Inc., Corning, NY, USA), and the COC was harvested. If the COC was not obtained in the original aspiration, then flushing was performed five times.
The COCs were graded according to the following criteria, which are modified criteria of previous studies 18, 19 
| Intracytoplasmic sperm injection
The oocytes were separated from the cumulus cells by using .05%
hyaluronidase (Sigma-Aldrich Corporation, St. Louis, MO, USA) that was dissolved in the modified human tubal fluid (mHTF) medium (Kitazato Corporation) by pipetting. After denudation, the MII oocytes were cultured for ≥1 hour. 20 Several spermatozoa were picked up, washed with a 5 μL drop of 5% polyvinylpyrrolidone (Irvine Scientific, Santa Ana, CA, USA) that was dissolved in mHTF with 10% serum protein substitute, and immobilized. The oocytes were inseminated through ICSI by using injection pipettes (inner diameter: 4.7 μm; outer diameter: 6.0 μm; Cook Medical, Bloomington, IN, USA). 21 The level of oolemma stretchability was evaluated, as described previously. 9 In brief, the oolemma stretchability during ICSI was evaluated by using an additional mechanical stimulus for oolemma penetration; that is, with or without aspiration (high vs low stretchability, respectively). To ensure objectivity, 
| Statistical analysis
The mean age of the patients was evaluated by using the TukeyKramer post-hoc test and is presented as the mean ± standard deviation. The rates of oocyte retrieval, oocyte maturity, COC grade, and oocyte stretchability were evaluated by using the chi-square test and residual analysis for multiple comparisons. The rates of fertilization, embryo cleavage, ≥7 cells on day 3, and blastocyst development were evaluated by using the chi-square test between two groups. A P-value of <.05 was considered to be statistically significant.
| RE SULTS
The follicular diameter was correlated with the FF volume that was aspirated from individual follicles (Spearman's rank-order correlation coefficient: .8421, P < .001; data not shown). Table 3 ).
There were no significant differences in the rates of oocytes with one PN, oocytes with multiple PNs, unfertilized oocytes, and degenerated oocytes after ICSI among all groups (Table 3) . Moreover, regarding embryonic development, there were no significant differences in the rates of embryo cleavage and ≥7 cells on day 3 after ICSI among all groups ( 
| D ISCUSS I ON
This study's results demonstrated that the GnRH agonist protocolderived MII oolemma from a low FF volume has low stretchability,
suggesting that the FF volume of individual follicles potentially was associated with the MII oolemma stretchability.
These results showed that the rate of oocyte retrieval from <1.0 mL of FF was low. Even if the COC was obtained, the rate of mature oocyte retrieval was low and that of immature oocyte retrieval was high. Several previous studies have reported that the oocyte maturity rate is associated with the follicular volume/diameter, [22] [23] [24] which is consistent with the current findings.
TA Values are presented as N (%). The number of retrieved oocytes and metaphase II, immature (MII and germinal vesicle), and degenerated oocytes were evaluated by using the chi-square test and residual analysis. A P-value of <.05 was considered to be statistically significant. *P < .05 and **P < .01.
The incidence of low oolemma stretchability significantly increased when the aspirated FF volume was <1.0 mL during ICSI.
This finding is consistent with that of the GnRH antagonist protocolderived MII oocytes in the authors' previous study. 9 Accordingly, the FF volume of individual follicles is associated with MII oolemma stretchability, regardless of the type of COS protocol. Therefore, these results speculated that the oolemma stretchability was affected by oocyte maturation, rather than by the COS protocol. Then, the focus was on oocyte maturation and it was found that the follicular size/volume is related to oocyte immaturity, which is relatively higher in oocytes from small follicles. 22, 25 During oocyte maturation, microfilaments and microtubules are spatially rearranged in the cortical and subcortical regions of the germinal vesicle oocytes.
26-28
Microvillous activity increases as MII is approached and during the abstraction of the PBs, which conglomerate in the constriction zone. 28 Moreover, the germinal vesicle oocyte funnel volume following ICSI is significantly less than that of MI and MII oocytes; that is, cytoplasmic viscosity remarkably changes from an aqueous to a more viscous subtype. 4 These studies showed that components of the oolemma or cytoplasm differ, depending on the oocyte stage, TA B L E 2 Relationship between the volume of follicular fluid that was aspirated from individual follicles and oolemma stretchability during intracytoplasmic sperm injection Values are presented as N (%) or mean ± standard deviation. The mean age of the patients was evaluated by using the Tukey-Kramer post-hoc test. The rates of oolemma stretchability and COC grades were evaluated by using the chi-square test and residual analysis. A P-value of <.05 was considered to be statistically significant. *P < .05.
TA B L E 3
Relationship between the volume of follicular fluid that was aspirated from individual follicles and the fertilization rate Values are presented as N (%). The rates of oocytes with two PNs and two PBs, one PN, or multiple PNs, unfertilized oocytes, and degenerated oocytes were evaluated using the chi-square test for between group A and each group. A p-value of <.05 was considered statistically significant. *P < .05: significant difference between groups A and C.
and that components of the oocyte drastically change during oocyte maturation. 29 Therefore, it was speculated that even if an oocyte from a small FF volume is in stage MII, differences in the FF volume and microenvironment potentially can affect the rearrangement of the oolemmic or cytoplasmic components during oocyte maturation after hCG injection and that the incidence of low oolemma stretchability is relatively greater in the MII oocytes that are derived from a small FF volume during ICSI.
The FF volume was not associated with the rates of the COC grade, including the MII oocytes. Hence, the impact on low stretchability in this study is unlikely to be related to the COC grades, in- showed that the FF volume had an impact on the fertilization rate.
A previous study showed that the fertilization rate of low-quality oocytes, such as with a fragile oolemma, was low. 8 Accordingly, it was speculated that the reduction of the normal fertilization rate in the low FF volume (<1.0 mL) group was associated with an increasing incidence of low oolemma stretchability.
Regarding embryonic development, the follicular size and oocyte developmental factors, such as cleavage, implantation, clinical pregnancy, and live birth, were not closely related and thus were considered to be independent. 30 Moreover, one study reported by time-lapse analysis that the presence of a fragile oolemma does not affect the subsequent fertilization and developmental processes of fragile oocytes. 8 However, this study's results showed that the FF volume had an impact on the blastocyst development and that the rate of blastocyst development was low in the <1.0 mL group, including more low stretchability oocytes. Accordingly, it was speculated that the reduction of the blastocyst development rate in the <1.0 mL group was associated with the FF volume and an increasing incidence of low oolemma stretchability.
The application of these results is limited because of the retrospective nature of the analysis. The association of the FF volume with the rates of pregnancy and live births also were not analyzed because two embryos or blastocysts frequently were transferred into the uterus in accordance with the recommendations of the Japan Society for Obstetrics and Gynecology.
31
In conclusion, the FF volume potentially is associated with human MII oolemma stretchability during ICSI, regardless of the type of COS protocol. Moreover, a low FF volume-derived oocyte tended to have low fertilization and blastocyst development abilities. In terms of oolemma stretchability, oocyte maturity, fertilization, and development, ensuring a uniform follicular size during COS is crucial for obtaining good-quality oocytes.
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